Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> Africa’s Methane Gamble – Can A Climate-Warming Gas Become An Asset to Health? 07/11/2021 Paul Adepoju & Elaine Ruth Fletcher GLASGOW – Nearly two dozen African countries, including some of the continent’s biggest methane- producing nations, have now signed The Global Methane Pledge, launched Tuesday at COP26 by United States President Joe Biden and the President of the European Commission, Ursula von der Leyen. While the pledge was initially announced in September with nine countries […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Can COVAX Finally Deliver on its Delayed Vaccine Promises? 20/10/2021 Kerry Cullinan The global vaccine facility, COVAX, is on the cusp of delivering large amounts of vaccines to countries that need them the most – but will poorer countries have the ability to properly absorb these? And how can COVAX ensure that it has the trust of low and middle-income countries (LMICs) who need the vaccines most, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> Africa’s Methane Gamble – Can A Climate-Warming Gas Become An Asset to Health? 07/11/2021 Paul Adepoju & Elaine Ruth Fletcher GLASGOW – Nearly two dozen African countries, including some of the continent’s biggest methane- producing nations, have now signed The Global Methane Pledge, launched Tuesday at COP26 by United States President Joe Biden and the President of the European Commission, Ursula von der Leyen. While the pledge was initially announced in September with nine countries […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Can COVAX Finally Deliver on its Delayed Vaccine Promises? 20/10/2021 Kerry Cullinan The global vaccine facility, COVAX, is on the cusp of delivering large amounts of vaccines to countries that need them the most – but will poorer countries have the ability to properly absorb these? And how can COVAX ensure that it has the trust of low and middle-income countries (LMICs) who need the vaccines most, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Africa’s Methane Gamble – Can A Climate-Warming Gas Become An Asset to Health? 07/11/2021 Paul Adepoju & Elaine Ruth Fletcher GLASGOW – Nearly two dozen African countries, including some of the continent’s biggest methane- producing nations, have now signed The Global Methane Pledge, launched Tuesday at COP26 by United States President Joe Biden and the President of the European Commission, Ursula von der Leyen. While the pledge was initially announced in September with nine countries […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Can COVAX Finally Deliver on its Delayed Vaccine Promises? 20/10/2021 Kerry Cullinan The global vaccine facility, COVAX, is on the cusp of delivering large amounts of vaccines to countries that need them the most – but will poorer countries have the ability to properly absorb these? And how can COVAX ensure that it has the trust of low and middle-income countries (LMICs) who need the vaccines most, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> Can COVAX Finally Deliver on its Delayed Vaccine Promises? 20/10/2021 Kerry Cullinan The global vaccine facility, COVAX, is on the cusp of delivering large amounts of vaccines to countries that need them the most – but will poorer countries have the ability to properly absorb these? And how can COVAX ensure that it has the trust of low and middle-income countries (LMICs) who need the vaccines most, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Can COVAX Finally Deliver on its Delayed Vaccine Promises? 20/10/2021 Kerry Cullinan The global vaccine facility, COVAX, is on the cusp of delivering large amounts of vaccines to countries that need them the most – but will poorer countries have the ability to properly absorb these? And how can COVAX ensure that it has the trust of low and middle-income countries (LMICs) who need the vaccines most, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Pandemic Treaty: US Proposes Amending Existing International Health Rules First; Germany Presses for Sanctions 03/09/2021 Kerry Cullinan While a “pandemic treaty” could take years to establish, the World Health Organization’s (WHO) International Health Regulations (IHR) could be revised more rapidly to significantly improve global disease outbreak response, top US officials are saying. The statements coincided with a 3-day working group meeting of WHO member states to discuss ways to strengthen the global […] Continue reading -> Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
Boosters: Laboratory Evidence Needs to be Balanced with Field-based Data 03/08/2021 Svĕt Lustig Vijay This article is the third in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Alongside the heated policy debate over the disproportionate consumption of COVID vaccines in rich countries, a handful of senior scientists are pushing back against the scientific […] Continue reading -> COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts
COVID Vaccine Boosters in Immuno-compromised People – Could They Also Help Curb Development of New Variants ? 02/08/2021 Svĕt Lustig Vijay This article is the second in a three-part series on COVID-19 booster vaccines, which is an evolving discussion as more evidence emerges about the performance of vaccines against variants. Despite heated debates about doling out booster jabs in healthy people who are already fully vaccinated against SARS-CoV-2, there seems to be consensus that at least […] Continue reading -> Posts navigation Older postsNewer posts